Kiniksa Pharmaceuticals

KNSA

Market cap $3.37B

Buy

Hold

Sell

3 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target

Avg. target

$56

26% upside

High target

positive

0 neutral

negative

Analyst & Firm	Rating	Price Target	Upside Downside	Date
Wells Fargo Eva Fortea Verdejo 100% 1-yr KNSA win rate				25 Feb ‘26 4 days ago
Wedbush David Nierengarten 100% 1-yr KNSA win rate				25 Feb ‘26 4 days ago
Canaccord Genuity Edward Nash 0% 1-yr KNSA win rate				19 Feb ‘26 10 days ago